Exact Sciences
Aggregated from S&P 500 earnings calls
Total Mentions
28
Companies
1
Sentiment
BULLISH 1
Mentions by Company
Abbott LaboratoriesQ3-2025
28×BULLISH
“Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments”
“Exact Sciences is projected to generate more than $3 billion in revenue this year, with a high teens organic sales growth rate”
“Exact Sciences shareholders will receive $105 per common share, representing a total equity value of approximately $21 billion”